The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Cancer incidence and risk factors after solid organ transplantation
Abstract
Iatrogenic immunosuppression is a unique setting for investigating immune‐related mechanisms of carcinogenesis. Solid organ transplant recipients have a 3‐fold excess risk of cancer relative to the age‐ and sex‐matched general population. Population‐based studies utilizing cancer registry records indicate that a wide range of cancers, mostly those with a viral etiology, occur at excess rates. To date, cancer risk has predominantly been examined in adult kidney transplant recipients in Western countries. It is yet to be established whether a similar incidence profile exists in the long‐term for other solid organ, pediatric and non‐Western transplant recipients. The cancer incidence profile before and after kidney transplantation strongly suggests a relatively minor contribution by both preexisting cancer risk factors and the conditions underlying end‐stage kidney disease, and points to a causal role for immunosuppression. Within‐cohort risk factor analyses have largely been performed on cohorts with voluntary cancer notification, and very few have incorporated biomarkers of the level of immunosuppression, the current receipt of immunosuppressive agents, or genetic risk factors. Because of their markedly high risk of certain cancers, findings from comprehensive studies in transplant recipients have the potential to raise new avenues for investigation into causal mechanisms and preventive measures against immune‐related and infectious causes of cancer. © 2009 UICC
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grulich, A. E., van Leeuwen, M. T., Falster, M. O., & Vajdic, C. M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61050-2 · Cited by 2,323
Self-citationSkin cancers after organ transplantation
Euvrard, S., Kanitakis, J., & Claudy, A. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022137 · Cited by 1,575
Starzl, T. E., Porter, K. A., Iwatsuki, S., Rosenthal, J. T., Shaw, B. W., Atchison, R. W., Nalesnik, M., Ho, M., Griffith, B. P., Hakala, T. R., et al. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90994-2 · Cited by 1,234
Cancer Incidence Before and After Kidney Transplantation
Vajdic, C. M., McDonald, S. P., McCredie, M. R. E., van Leeuwen, M. T., Stewart, J. H., Law, M., Chapman, J. R., Webster, A. C., Kaldor, J. M., & Grulich, A. E. (2006) · JAMA · doi:10.1001/jama.296.23.2823 · Cited by 1,130
Self-citationLymphomas After Solid Organ Transplantation: A Collaborative Transplant Study Report
Opelz, G., & Döhler, B. (2004) · American Journal of Transplantation · doi:10.1046/j.1600-6143.2003.00325.x · Cited by 1,081
Jensen, P., Hansen, S., Møller, B., Leivestad, T., Pfeffer, P., Geiran, O., Fauchald, P., & Simonsen, S. (1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70185-4 · Cited by 871
Dantal, J., Hourmant, M., Cantarovich, D., Giral, M., Blancho, G., Dreno, B., & Soulillou, J.-P. (1998) · The Lancet · doi:10.1016/s0140-6736(97)08496-1 · Cited by 745
Cancer risk following organ transplantation: a nationwide cohort study in Sweden
Adami, J., Gäbel, H., Lindelöf, B., Ekström, K., Rydh, B., Glimelius, B., Ekbom, A., Adami, H.-O., & Granath, F. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601219 · Cited by 692
Incidence of non-hodgkin lymphoma in kidney and heart transplant recipients
Opelz, G., & Henderson, R. (1993) · The Lancet · doi:10.1016/s0140-6736(05)80084-4 · Cited by 648
Azathioprine and UVA Light Generate Mutagenic Oxidative DNA Damage
O'Donovan, P., Perrett, C. M., Zhang, X., Montaner, B., Xu, Y.-Z., Harwood, C. A., McGregor, J. M., Walker, S. L., Hanaoka, F., & Karran, P. (2005) · Science · doi:10.1126/science.1114233 · Cited by 631
Cited by
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Microenvironmental regulation of tumor progression and metastasis
Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994
Spectrum of cancer risk among US solid organ transplant recipients
Engels, E. A., Pfeiffer, R. M., Fraumeni, J. F., Kasiske, B. L., Israni, A. K., Snyder, J. J., Wolfe, R. A., Goodrich, N. P., Bayakly, A. R., Clarke, C. A., et al. (2011) · JAMA · doi:10.1001/jama.2011.1592 · Cited by 1,524
Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation
Dhatchinamoorthy, K., Colbert, J. D., & Rock, K. L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.636568 · Cited by 1,077
Why do viruses cause cancer? Highlights of the first century of human tumour virology
Moore, P. S., & Chang, Y. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2961 · Cited by 745
Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways
Schetter, A. J., Heegaard, N. H. H., & Harris, C. C. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp272 · Cited by 657
Forsberg, L. A., Rasi, C., Malmqvist, N., Davies, H., Pasupulati, S., Pakalapati, G., Sandgren, J., de Ståhl, T. D., Zaghlool, A., Giedraitis, V., et al. (2014) · Nature Genetics · doi:10.1038/ng.2966 · Cited by 458
Krynitz, B., Edgren, G., Lindelöf, B., Baecklund, E., Brattström, C., Wilczek, H., & Smedby, K. E. (2013) · International Journal of Cancer · doi:10.1002/ijc.27765 · Cited by 376
Metadata
- Authors
- Vajdic, C. M., & van Leeuwen, M. T.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2009-05-14
- Volume
- 125
- Issue
- 8
- Pages
- 1747-1754
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W1983934840
- Cited by
- 459
- References
- 60
- FWCI
- 12.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.